AMICUS THERAPEUTICS INC's ticker is FOLD and the CUSIP is 03152W109. A total of 210 filers reported holding AMICUS THERAPEUTICS INC in Q2 2019. The put-call ratio across all filers is 1.10 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $181,000 | +1545.5% | 18,600 | +1966.7% | 0.04% | +1100.0% |
| Q2 2019 | $11,000 | -79.2% | 900 | -75.7% | 0.00% | -75.0% |
| Q4 2017 | $53,000 | -89.0% | 3,700 | -88.4% | 0.01% | -88.8% |
| Q3 2017 | $483,000 | -19.5% | 32,000 | -46.3% | 0.11% | +21.6% |
| Q2 2017 | $600,000 | +3.4% | 59,562 | -26.7% | 0.09% | +31.3% |
| Q1 2017 | $580,000 | +673.3% | 81,296 | +438.4% | 0.07% | +644.4% |
| Q4 2016 | $75,000 | -87.4% | 15,100 | -81.3% | 0.01% | -88.3% |
| Q3 2016 | $596,000 | +39.6% | 80,586 | +2.9% | 0.08% | +30.5% |
| Q2 2016 | $427,000 | -39.9% | 78,286 | -6.8% | 0.06% | -28.0% |
| Q1 2016 | $710,000 | +24.6% | 83,990 | +42.9% | 0.08% | +15.5% |
| Q4 2015 | $570,000 | +254.0% | 58,759 | +410.9% | 0.07% | +294.4% |
| Q3 2015 | $161,000 | – | 11,500 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 10,524,022 | $127,972,108 | 12.11% |
| Perceptive Advisors | 27,692,917 | $336,745,870 | 11.23% |
| Redmile Group, LLC | 16,944,621 | $206,046,591 | 9.80% |
| Finepoint Capital LP | 1,489,025 | $18,106,544 | 9.02% |
| CM Management, LLC | 450,000 | $5,472,000 | 5.81% |
| Avoro Capital Advisors LLC | 27,400,000 | $333,184,000 | 5.20% |
| MPM BioImpact LLC | 716,139 | $8,708,250 | 2.32% |
| Artal Group S.A. | 4,062,567 | $49,401 | 2.12% |
| SECTORAL ASSET MANAGEMENT INC | 803,464 | $9,770,122 | 1.90% |
| GREAT POINT PARTNERS LLC | 857,000 | $10,421,120 | 1.90% |